Tumor-associated autoantibody signature for the early detection of gastric cancer

International Journal of Cancer

Volumn 132, Issue 1, 2013, Pages 137-147

  Zayakin, Pawel ^a   Ancans, Guntis ^b   Siliaņa, Karina ^a   Meistere, Irena ^a   Kalniņa, Zane ^a   Andrejeva, Diana ^a   Endzeliņš, Edgars ^a   Ivanova, Lasma ^a   Pismennaja, Angelina ^a   Ruskule, Agnese ^c   Doniņa, Simona ^b   Wex, Thomas ^d   Malfertheiner, Peter ^d   Leja, Marcis ^b,c   Line, Aija ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^b RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^c UNIVERSITY OF LATVIA   (Latvia)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

autoantibodies; biomarker; early detection; gastric cancer; phage displayed antigen microarray

Indexed keywords

CANCER ANTIBODY; COMPLEMENTARY DNA; PEPSINOGEN; RECOMBINANT DNA; TUMOR ANTIGEN;

ADULT; ADVANCED CANCER; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY STRUCTURE; ARTICLE; BACTERIOPHAGE T7; BLOOD SAMPLING; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SCREENING; CLINICAL FEATURE; CONTROLLED STUDY; DATA PROCESSING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DNA LIBRARY; EARLY DIAGNOSIS; FEMALE; GASTRITIS; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOREACTIVITY; INFLAMMATORY DISEASE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROARRAY ANALYSIS; PATIENT CARE; PEPTIC ULCER; PHAGE DISPLAY; PRIMARY TUMOR; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN FUNCTION; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEROLOGY; STOMACH CANCER; TUMOR IMMUNITY; TUMOR VOLUME; VALIDATION PROCESS;

AGED; ANTIGENS, NEOPLASM; AUTOANTIBODIES; BACTERIOPHAGE T7; EARLY DETECTION OF CANCER; FEMALE; GENE LIBRARY; HUMANS; INFLAMMATION; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SERUM; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84868208929     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27667     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Park JM, Kim YH,. Current approaches to gastric cancer in Korea. Gastrointest Cancer Res 2008; 2: 137-44.
3. Rosati G, Ferrara D, Manzione L,. New perspectives in the treatment of advanced or metastatic gastric cancer. World J Gastroenterol 2009; 15: 2689-92.
4. Sahin U, Tureci O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995; 92: 11810-13.
5. Mischo A, Wadle A, Watzig K, et al. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients. Cancer Immun 2003; 3: 5.
6. Tureci O, Sahin U, Pfreundschuh M,. Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today 1997; 3: 342-9.
7. Preuss KD, Zwick C, Bormann C, et al. Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev 2002; 188: 43-50.
8. Bei R, Masuelli L, Palumbo C, et al. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: inflammation in their induction and impact on tumor growth. Cancer Lett 2009; 281: 8-23.
9. Tan HT, Low J, Lim SG, et al. Serum autoantibodies as biomarkers for early cancer detection. FEBS J 2009; 276: 6880-904.
10. Kalnina Z, Silina K, Line A,. Autoantibody profiles as biomarkers for response to therapy and early detection of cancer. Curr Cancer Ther Rev 2008; 4: 149-56.
11. Preiss S, Kammertoens T, Lampert C, et al. Tumor-induced antibodies resemble the response to tissue damage. Int J Cancer 2005; 115: 456-62.
12. Klade CS, Voss T, Krystek E, et al. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 2001; 1: 890-8.
13. Philip R, Murthy S, Krakover J, et al. Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer. J Proteome Res 2007; 6: 2509-17.
14. Qiu J, Madoz-Gurpide J, Misek DE, et al. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res 2004; 3: 261-7.
15. Chatterjee M, Mohapatra S, Ionan A, et al. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006; 66: 1181-90.
16. Wang X, Yu J, Sreekumar A, et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005; 353: 1224-35.
17. Fernandez-Madrid F, Tang N, Alansari H, et al. Autoantibodies to annexin XI-A and other autoantigens in the diagnosis of breast cancer. Cancer Res 2004; 64: 5089-96.
18. Bouwman K, Qiu J, Zhou H, et al. Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity. Proteomics 2003; 3: 2200-7.
19. Obata Y, Takahashi T, Sakamoto J, et al. SEREX analysis of gastric cancer antigens. Cancer Chemother Pharmacol 2000; 46 (Suppl): S37-S42.
20. Line A, Stengrevics A, Slucka Z, et al. Serological identification and expression analysis of gastric cancer-associated genes. Br J Cancer 2002; 86: 1824-30.
21. Kalnina Z, Silina K, Bruvere R, et al. Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer. Eur J Histochem 2009; 53: 7-18.
22. Tsunemi S, Nakanishi T, Fujita Y, et al. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer. Oncol Rep 2010; 23: 949-56.
23. Kalnina Z, Silina K, Meistere I, et al. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients. J Immunol Methods 2008; 334: 37-50.
24. Wex T, Leodolter A, Bornschein J, et al. Interleukin 1 β (IL1β) gene polymorphisms are not associated with gastric carcinogenesis in Germany. Anticancer Res 2010; 30: 505-11.
25. Laxman B, Morris DS, Yu J, et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res 2008; 68: 645-9.
26. Silina K, Zayakin P, Kalnina Z, et al. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients. J Immunother 2011; 34: 28-44.
27. Greiner M,. Two-graph receiver operating characteristic (TG-ROC): update version supports optimisation of cut-off values that minimise overall misclassification costs. J Immunol Methods 1996; 191: 93-4.
28. Nesterova M, Johnson N, Cheadle C, et al. Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta 2006; 1762: 398-403.
29. Chen G, Wang X, Yu J, et al. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 2007; 67: 3461-7.
30. Zhong L, Coe SP, Stromberg AJ, et al. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006; 1: 513-19.
31. Anderson KS, Sibani S, Wallstrom G, et al. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J Proteome Res 2011; 10: 85-96.
32. Gnjatic S, Ritter E, Buchler MW, et al. Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci USA 2010; 107: 5088-93.
33. Gnjatic S, Wheeler C, Ebner M, et al. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. J Immunol Methods 2009; 341: 50-8.
34. Wong J, Sibani S, Lokko NN, et al. Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays. J Immunol Methods 2009; 350: 171-82.
35. Nielsen UB, Geierstanger BH,. Multiplexed sandwich assays in microarray format. J Immunol Methods 2004; 290: 107-20.
36. Schneider J, Schulze G,. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Anticancer Res 2003; 23: 5089-93.
37. Carpelan-Holmstrom M, Louhimo J, Stenman UH, et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res 2002; 22: 2311-16.
38. Dinis-Ribeiro M, Yamaki G, Miki K, et al. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004; 11: 141-7.
39. Hishida A, Matsuo K, Goto Y, et al. Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions. World J Gastrointest Oncol 2010; 2: 369-79.
40. Reuschenbach M, von Knebel DM, Wentzensen N,. A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother 2009; 58: 1535-44.
41. Stockert E, Jager E, Chen YT, et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998; 187: 1349-54.
42. Scanlan MJ, Gure AO, Jungbluth AA, et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32.
43. Zeng G, Aldridge ME, Wang Y, et al. Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker. Int J Cancer 2005; 114: 268-73.
44. Cho B, Lim Y, Lee DY, et al. Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem Biophys Res Commun 2002; 292: 715-26.
45. Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3: 991-8.
46. Andreu P, Johansson M, Affara NI, et al. FcRIγ activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 2010; 17: 121-34.
47. Willimsky G, Czeh M, Loddenkemper C, et al. Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. J Exp Med 2008; 205: 1687-700.